RGNX - Regenxbio - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

RGNX is currently covered by 5 analysts with an average price target of $37.18. This is a potential upside of $23.67 (175.2%) from yesterday's end of day stock price of $13.51.

Regenxbio's activity chart (see below) currently has 140 price targets and 138 ratings on display. The stock rating distribution of RGNX is 87.5% BUY and 12.5% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 26% with an average time for these price targets to be met of 76.16 days.

Highest price target for RGNX is $52, Lowest price target is $12, average price target is $28.2.

Most recent stock forecast was given by DANIIL GATAULIN from CHARDAN CAPITAL on 20-Nov-2025. First documented stock forecast 12-Oct-2015.

Currently out of the existing stock ratings of RGNX, 14 are a BUY (87.5%), 2 are a HOLD (12.5%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy

$52

$38.61 (288.35%)

28 days ago
(20-Nov-2025)

0/7 (0%)

$41.13 (378.38%)

Buy

$19

$5.61 (41.90%)

$25

1 months 11 days ago
(07-Nov-2025)

4/15 (26.67%)

$7.79 (69.49%)

50

Buy

$34

$20.61 (153.92%)

$34

3 months 10 days ago
(08-Sep-2025)

0/11 (0%)

$24.52 (258.65%)

Hold

$12

$-1.39 (-10.38%)

$14

8 months 1 days ago
(17-Apr-2025)

1/3 (33.33%)

$6.06 (102.02%)

174

Buy

$24

$10.61 (79.24%)

$22

9 months 4 days ago
(14-Mar-2025)

0/2 (0%)

$17.28 (257.14%)

Show more analysts

Please expand the browser size to see the chart

What is RGNX (Regenxbio) average time for price targets to be met?

On average it took 76.16 days on average for the stock forecasts to be realized with a an average price target met ratio 26

Which analyst has the current highest performing score on RGNX (Regenxbio) with a proven track record?

JOSH SCHIMMER

Which analyst has the most public recommendations on RGNX (Regenxbio)?

Josh Schimmer works at CANTOR FITZGERALD and has 3 price targets and 2 ratings on RGNX

Which analyst is the currently most bullish on RGNX (Regenxbio)?

Geulah Livshits with highest potential upside - $73.54

Which analyst is the currently most reserved on RGNX (Regenxbio)?

Paul Choi with lowest potential downside - -$1.39

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?